Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 741 results for "warner chilcott"

8-K - Warner Chilcott Ltd (0001620602) (Filer)

Filing Date 2015-03-10 Accepted 2015-03-10 17:28:53 Documents 4 Period of Report 2015-03-10 Filing Date Changed 2015-03-10 Items Item 8.01: Other Events Item 9.01: Financial Statements SEC Filings, 1 month ago
[x]  

WARNER CHILCOTT LTD - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Except for the historical information contained herein, the following discussion contains forward-looking statements that are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from ...
 Pharmacy Choice1 month ago ACTAVIS PLC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS  Pharmacy Choice1 month ago

Warner Chilcott Co, LLC v. Teva Pharms. USA, Inc

Winter 2014 Case Name: . , Nos. 2014-1439, 2014-1441, 2014-1444, 2014-1445, 2014-1446, 2014 U.S. App. LEXIS 21946 (Fed. Cir. Nov. 18, 2014) (Circuit Judges Lourie, Reyna and Taranto presiding; Opinion by Lourie, J.) (appeal from D. Del., Stark, ...
 JD Supra1 month ago

Judge Sides With Teva and Strikes Down Actavis's Atelvia Patents

A federal judge has sided with a Paragraph IV ANDA from Teva and struck down the patents protecting Actavis subsidiary Warner Chilcott's postmenopausal osteoporosis drug Atelvia. The New Jersey district court judge ruled in a patent ...
 FDA News1 month ago BRIEF-U.S. judge for Teva in patent litigation concerning Atelvia  Reuters UK1 month ago
Livemint.com

Glenmark receives ANDA approval for postmenopausal osteoporosis drug from FDA

Glenmark Generics Inc. USA has received the final abbreviated new drug approval, or ANDA, from the FDA for Norethindrone Acetate and Ethinyl Estradiol tablets USP, 0.5mg/2.5mcg and 1mg/5mcg, indicated for the prevention of postmenopausal ...
 Individual.com1 day ago Glenmark to launch generic of FemHRT  Chain Drug Review1 week ago Glenmark Gets US Regulatory Nod for Osteoporosis Drug  NDTV Profit1 week ago Glenmark gets US FDA approval for norethindrone acetate and ethinyl estradiol tablets USP  PharmaBiz1 week ago
[x]  

Paratek Pharmaceuticals: The Next Blockbuster Antibiotic At A Third Of The Valuation

Apr. 13, 2015 2:09 PM ET | About: Paratek Pharmaceuticals, Inc. (PRTK), Includes: ACT by: Bridging the Gap Summary Paratek's lead drug, Omadacycline, is a new type of antibiotic that can avoid the harmful effects of bacterial resistance to ...
 Seeking Alpha4 days ago Paratek Pharmaceuticals, Inc. Reports Full Year 2014 Financial and Operating Results  Town Hall2 weeks ago Paratek Pharmaceuticals to Present at Two Upcoming Investor Conferences  Pettinga Financial Advisors1 month ago Paratek Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences  BioSpace1 month ago
[x]  

Magnetar Capital Raises Its Stake in Actavis

Highlights: Magnetar Capital's Position Increases from 4Q14 13F (Part 6 of 7) ( Continued from Part 5 ) Magnetar and Actavis In the fourth quarter, Magnetar increased its exposure to Actavis (ACT). It bought 42,107 shares in the pharmaceutical ...
 Yahoo! Finance4 days ago
Pharmaceutical Online

FDA News Roundup: Novo Nordisk, AstraZeneca, Merck, And More

By Anna Rose Welch , associate editor What FDA decisions did you miss this week? Curis DLBCL Drug Named Orphan Drug The FDA granted Curis drug for Diffuse Large B-Cell Lymphoma orphan drug designation. CUDC-907 is a dual inhibitor of ...
 Pharmaceutical Online1 week ago

Pharmaceutical Newsletter - April 06 to 10, 2015

Top News Dr. Reddy's Lab, Promius Pharma announces filing of three NDAs with USFDA Dr. Reddy's Laboratories and its subsidiary, Promius Pharma, LLC announced the filing of three 505(b)(2) New Drug Applications (NDAs) with the U.S. Food and Drug ...
 India Infoline1 week ago
Citybizlist

Kramer Levin Adds Litigators Brian Slater and Gregory Sephton to Life Sciences Practice

Kramer Levin Naftalis & Frankel reported that Brian Slater and Gregory Sephton have joined the firm in New York as partners in the intellectual property department. The company said that Slater and Sephton both have extensive experience handling ...
 Individual.com1 week ago Kramer Levin Appoints Brian Slater And Gregory Sephton  Citybizlist1 week ago Kramer Levin Expands Life Sciences Practice with the Hiring of Patent Litigators Brian Slater and Gregory Sephton  Pettinga Financial Advisors1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - warner chilcott
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less